Not Signed In -
Lopinavir and Ritonavir |
Kaletra; lopinavir/ritonavir |
Lopinavir Systematic (IUPAC) name (2S)-N-[(2S,4S,5S)-5-{[2-(2,6-dimethylphenoxy) acetyl]amino}-4-hydroxy-1,6-diphenyl-hexan-2-yl]- 3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide Identifiers CAS number ? ATC code J05AE06 PubChem 92727 DrugBank EXPT00388 Chemical data Formula C37H48N4O5 Mol. weight 628.810 g/mol Pharmacokinetic data Bioavailability Unknown Protein binding 99% Metabolism Hepatic Half life 5 to 6 hours Excretion Mostly fecal T ...
Wikipedia - [full article]
Resources
- Kaletra (Drug Digest)
- Kaletra Consumer Information (U.S. Food and Drug Administration)
Lopinavir and Ritonavir News Headlines
- Interim Analysis Of New Study Suggests Boosted INVIRASE(R) May Achieve Similar Levels Of HIV Suppression To Boosted Lopinavir
MedicalNewsToday - Tue, 14 Nov 2006 08:00 EST
- Abbott Statement Regarding New Initiatives To Expand Access And Affordability To Lopinavir/ritonavir In The Developing World
MedicalNewsToday - Sun, 20 Aug 2006 07:00 EST
- Aptivus®(tipranavir) Demonstrates Durable Response Through Nearly Two Years
MedicalNewsToday - Sun, 15 Oct 2006 07:00 EST
- Head-to-head Study Comparing Lexiva® (fosamprenavir Calcium) To Kaletra Presented At IAC 2006 And Published In The Lancet
MedicalNewsToday - Sun, 20 Aug 2006 06:00 EST
- Head-to-Head Study Comparing LEXIVA(R) (Fosamprenavir Calcium) To Kaletra Presented At IAC 2006 And Published In The Lancet
MedicalNewsToday - Fri, 18 Aug 2006 07:00 EST
- HIV - New Tablet Formulation Of Kaletra® (lopinavir/ritonavir) Approved In Europe
MedicalNewsToday - Sun, 09 Jul 2006 04:00 EST
- Antiretroviral Drug Lopinavir Selectively Kills HPV-Infected Cells In Lab Tests, Study Says
MedicalNewsToday - Wed, 30 Aug 2006 07:00 EST
- Abbott's New Tablet Formulation Of Kaletra(R) (lopinavir/ritonavir) Approved In Europe
MedicalNewsToday - Tue, 04 Jul 2006 06:00 EST
- New HIV Drug Accepted By Scottish Medicines Consortium
MedicalNewsToday - Wed, 13 Sep 2006 06:00 EST
- Experimental Antiretroviral Combination Therapy Effective In Reducing Viral Loads In Children, Boehringer Ingelheim Study Says
MedicalNewsToday - Fri, 18 Aug 2006 12:00 EST
- Abbott's New Tablet Formulation Of Kaletra(R) (Lopinavir/Ritonavir) Receives Positive Opinion From The European Medicines Agency
MedicalNewsToday - Sun, 30 Apr 2006 06:00 EST
- Preliminary 48-Week Results From Clinical Study Of HIV Protease Inhibitors Lexiva (Telzir) And Kaletra In Treatment-naive Patients With HIV
MedicalNewsToday - Wed, 17 May 2006 06:00 EST
- Abbott Letter To MSF On HIV Treatment Access In Developing Countries
MedicalNewsToday - Thu, 23 Mar 2006 11:00 EST
- Abbott Statement on Agreement With Brazilian Government for Kaletra(R) (Lopinavir/Ritonavir)
MedicalNewsToday - Mon, 11 Jul 2005 05:00 EST
- Abbott Submits Application To EMEA For A New, More Convenient Kaletra® Formulation
MedicalNewsToday - Mon, 25 Jul 2005 11:00 EST
- Patients treated with boosted Invirase, a potent anti-HIV treatment, do not develop resistance
MedicalNewsToday - Wed, 27 Jul 2005 11:00 EST
- FDA Approves New HIV Therapy, Aptivus Capsules with Ritonavir
MedicalNewsToday - Fri, 24 Jun 2005 05:00 EST
email this page
print this page
bookmark this page
feedback on this page
